These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 26366474)

  • 1. Integrating Molecular Testing in the Diagnosis and Management of Children with Thyroid Lesions.
    Ballester LY; Sarabia SF; Sayeed H; Patel N; Baalwa J; Athanassaki I; Hernandez JA; Fang E; Quintanilla NM; Roy A; López-Terrada DH
    Pediatr Dev Pathol; 2016; 19(2):94-100. PubMed ID: 26366474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application value of multi-gene mutation detection in the clinical management of pediatric papillary thyroid carcinoma: a preliminary exploration.
    Wang Y; Wang H; Tan G; Wu X; Wang B; Tan Z; Du J; Li X; Xu Y; Yan N; Qian X
    Front Endocrinol (Lausanne); 2024; 15():1405142. PubMed ID: 38904052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Facilitation of Definitive Cancer Diagnosis With Quantitative Molecular Assays of BRAF V600E and TERT Promoter Variants in Patients With Thyroid Nodules.
    Fu G; Chazen RS; Monteiro E; Vescan A; Freeman JL; Witterick IJ; MacMillan C
    JAMA Netw Open; 2023 Jul; 6(7):e2323500. PubMed ID: 37505499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Shift in Molecular Drivers of Papillary Thyroid Carcinoma Following the 2017 World Health Organization Classification: Characterization of 554 Consecutive Tumors With Emphasis on BRAF-Negative Cases.
    Hang JF; Chen JY; Kuo PC; Lai HF; Lee TL; Tai SK; Kuo CS; Chen HS; Li WS; Li CF
    Mod Pathol; 2023 Sep; 36(9):100242. PubMed ID: 37307878
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted sequencing of DNA/RNA combined with radiomics predicts lymph node metastasis of papillary thyroid carcinoma.
    Zhang R; Hu L; Cheng Y; Chang L; Dong L; Han L; Yu W; Zhang R; Liu P; Wei X; Yu J
    Cancer Imaging; 2024 Jun; 24(1):75. PubMed ID: 38886866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RET fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis.
    Bulanova Pekova B; Sykorova V; Mastnikova K; Vaclavikova E; Moravcova J; Vlcek P; Lancova L; Lastuvka P; Katra R; Bavor P; Kodetova D; Chovanec M; Drozenova J; Matej R; Astl J; Hlozek J; Hrabal P; Vcelak J; Bendlova B
    Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Defining the Genomic Landscape of Diffuse Sclerosing Papillary Thyroid Carcinoma: Prognostic Implications of RET Fusions.
    Scholfield DW; Fitzgerald CWR; Boe LA; Eagan A; Levyn H; Xu B; Tuttle RM; Fagin JA; Shaha AR; Shah JP; Wong RJ; Patel SG; Ghossein R; Ganly I
    Ann Surg Oncol; 2024 Sep; 31(9):5525-5536. PubMed ID: 38847983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient with multiple genetically distinct thyroid nodules including papillary thyroid carcinoma harboring novel YWHAG-BRAF fusion.
    Lin R; Wang ZX; Cottrill E; Badjatia N; Gargano SM
    Cancer Genet; 2022 Aug; 266-267():51-56. PubMed ID: 35780657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding the Spectrum of
    De Leo A; Serban D; Maloberti T; Sanza V; Coluccelli S; Altimari A; Gruppioni E; Chiarucci F; Corradini AG; Repaci A; Colapinto A; Nannini M; Pantaleo MA; de Biase D; Tallini G
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular Genetics Augment Cytopathologic Evaluation and Surgical Planning of Pediatric Thyroid Nodules.
    Spaulding SL; Maayah M; Dinauer CA; Prasad M; Darbinyan A; Morotti R; Christison-Lagay ER
    J Pediatr Surg; 2024 May; 59(5):975-980. PubMed ID: 38246817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Preoperative Molecular Testing and Implications for Initial Surgical Management in Thyroid Nodules Harboring Suspected (Bethesda V) or Known (Bethesda VI) Papillary Thyroid Cancer.
    Schumm MA; Shu ML; Hughes EG; Nikiforov YE; Nikiforova MN; Wald AI; Lechner MG; Tseng CH; Sajed DP; Wu JX; Yeh MW; Livhits MJ
    JAMA Otolaryngol Head Neck Surg; 2023 Aug; 149(8):735-742. PubMed ID: 37382944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Digital droplet PCR TERT promoter mutational screening in fine needle aspiration cytology of thyroid lesions: A highly specific technique for pre-operative identification of high-risk cases.
    Hysek M; Hellgren LS; Stenman A; Darai-Ramqvist E; Ljung E; Schliemann I; Condello V; Larsson C; Zedenius J; Jatta K; Juhlin CC
    Diagn Cytopathol; 2023 Jun; 51(6):331-340. PubMed ID: 36870048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Approach to risk stratification for papillary thyroid carcinoma based on molecular profiling: institutional analysis.
    Staubitz JI; Müller C; Heymans A; Merten C; Roos B; Poplawski A; Ludt A; Strobl S; Springer E; Schad A; Roth W; Musholt TJ; Hartmann N
    BJS Open; 2023 May; 7(3):. PubMed ID: 37146205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of DP-TOF Mass Spectroscopy (MS) and Next Generation Sequencing (NGS) methods for detecting molecular mutations in thyroid nodules fine needle aspiration biopsies.
    Qian XQ; Agyekum EA; Zhao LL; Yu RL; Li XY; Gu DJ; Yan N; Xu M; Yuan Y; Wang YG; Xin-Ping W; Xu FJ
    Front Endocrinol (Lausanne); 2022; 13():928788. PubMed ID: 35992139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of BRAF or TERT Promoter Mutations and Advanced Papillary Thyroid Carcinoma.
    Toda S; Saito N; Kadoya M; Okubo Y; Yamazaki H; Suganuma N; Iwasaki H; Masudo K; Hoshino D
    Anticancer Res; 2024 Jul; 44(7):3141-3147. PubMed ID: 38925831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-generation sequencing identified that RET variation associates with lymph node metastasis and the immune microenvironment in thyroid papillary carcinoma.
    Huang Y; Lin P; Liao J; Liang F; Han P; Fu S; Jiang Y; Yang Z; Tan N; Huang J; Chen R; Ouyang N; Huang X
    BMC Endocr Disord; 2024 May; 24(1):68. PubMed ID: 38734621
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic landscape of metastatic papillary thyroid carcinoma and novel biomarkers for predicting distant metastasis.
    Lan X; Bao H; Ge X; Cao J; Fan X; Zhang Q; Liu K; Zhang X; Tan Z; Zheng C; Wang A; Chen C; Zhu X; Wang J; Xu J; Zhu X; Wu X; Wang X; Shao Y; Ge M
    Cancer Sci; 2020 Jun; 111(6):2163-2173. PubMed ID: 32187423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The relationship between differentially expressed thyroid cancer genes and clinical characteristics in metastatic children and adolescents].
    Pan YJ; Ju GD; Mu ZZ; Sun YQ; Sun D; Liang J; Lin YS
    Zhonghua Yi Xue Za Zhi; 2024 May; 104(20):1837-1843. PubMed ID: 38782752
    [No Abstract]   [Full Text] [Related]  

  • 19. Performance of multigene testing in cytologically indeterminate thyroid nodules and molecular risk stratification.
    Zhou Y; Wu X; Zhang Y; Li Z; Ge X; Chen H; Mao Y; Ding W
    PeerJ; 2023; 11():e16054. PubMed ID: 37744220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutation profiles of follicular thyroid tumors by targeted sequencing.
    Duan H; Liu X; Ren X; Zhang H; Wu H; Liang Z
    Diagn Pathol; 2019 May; 14(1):39. PubMed ID: 31077238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.